Prenetics Global Ltd (PRE)
4.81
-0.07
(-1.43%)
USD |
NASDAQ |
Nov 14, 16:00
4.49
-0.32
(-6.65%)
After-Hours: 20:00
Prenetics Global Total Liabilities (Quarterly): 42.30M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 42.30M |
| March 31, 2024 | 40.82M |
| December 31, 2023 | 44.01M |
| September 30, 2023 | 47.63M |
| June 30, 2023 | 60.62M |
| March 31, 2023 | 57.51M |
| Date | Value |
|---|---|
| December 31, 2022 | 68.67M |
| September 30, 2022 | 62.33M |
| June 30, 2022 | 59.24M |
| March 31, 2022 | 594.61M |
| December 31, 2021 | 549.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
40.82M
Minimum
Mar 2024
594.61M
Maximum
Mar 2022
147.92M
Average
59.24M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 3.382B |
| HUTCHMED (China) Ltd | 508.85M |
| Pharmaron Beijing Co Ltd | 1.420B |
| Regencell Bioscience Holdings Ltd | 0.2195M |
| Uni-Bio Science Group Ltd | 22.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 233.31M |
| Shareholders Equity (Quarterly) | 188.24M |
| Current Ratio | 2.055 |